socalTECH

FEBRUARY 24, 2014

San Diego-based venture investor Avalon Ventures has scored an exit this morning, after IBM said it has acquired Boston-based Cloudant , a developer of a NoSQL-based, cloud-based database. Cloudant had been backed by Avalon Ventures, Devonshire Investors, In-Q-Tel, Rackspace, Samsung, and Toba Capital, and had only raised around $14.0M

Avalon 173

Avalon IBM IBM San Diego 173

socalTECH

MARCH 15, 2012

San Diego-based Avalon Ventures , one of the venture capital investors in social gaming phenomenon Zynga , may be set to cash in on its shares of the newly public gaming firm, after Zynga said this week that it is planning a $400M, secondary offering of its stock.

Avalon 150

Avalon SoCal Southern California San Diego 150

socalTECH

JULY 16, 2013

In the latest positive move for the Los Angeles venture capital market, a new investor has moved into town, to take advantage of the area''s growing startup market. core innovation capital venture investment fund' The firm''s efforts here are headed by Arjun Schutte. READ MORE>>.

Capital 174

Capital Southern California Avalon SoCalTech 174

socalTECH

JULY 14, 2017

Financial terms of the acquisition were not announced. StackIQ was venture backed by Anthem Venture Partners, Grayhawk Capital, Avalon Ventures, and crowdfunding site OurCrowd. San Diego-based StackIQ , a developer of "bare metal" provisioning software, has been acquired by Teradata , Teradata said on Thursday.

Avalon 113

Avalon Anthem San Diego Acquisition 113

socalTECH

JULY 1, 2011

Among the investors who may benefit from a successful IPO are La Jolla-based Avalon Ventures , run by Kevin Kinsella, Stephen Tomlin, Richard Levandov, Brady Bohrmann, Doug Downs and Jay Lichter, which before the IPO owned 6.1 According to Zynga, it is looking to raise up to $1 billion on the public markets. percent of Zynga.

Avalon 140

Avalon Southern California Class Marketing 140

socalTECH

JUNE 11, 2021

The company's biggest shareholders before the IPO were Avalon Ventures, RA Capital Healthcare, Orbimed, Bregua Corporation, and Correlation Ventures. According to the company, the gross proceeds from the effort are expected to be $193.8M. Janux Therapeutics is developing T cell engager immunotherapies.

Pricing 113

Pricing Avalon Capital Marketing 113

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56